HSS presents oligonucleotide CDMO business 
based on our experience To contribute in reasearch and medical fields HSS presents oligonucleotide CDMO business 
based on our experience To contribute in reasearch and medical fields

News

More

2025.12.12 News

Re: Business calendar for year changing period

2025.10.15 News

Launch of Oligonucleotide CRDMO Service Website

2025.10.07 News

Business Collaboration Agreement with TRANSGENIC GROUP INC. and TRANSGENIC INC.

2025.07.22 News

Re: Business calendar for summer holidays

2025.06.30 News

“Oligonucleotide API CDMO” category is newly available

More

Service

More

2026.02.16 Service

New “Animal Experimentation” page for CDMO services Animal studies are offered to support projects from drug discovery to development.

2024.11.26 Service

New Additions to the Stock Series Lineup

More
Page Top